Cited by 136Cervical Cancer and HPV ResearchWomen's cancer prevention and managementVaccine Coverage and Hesitancy

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

Sankaranarayanan, Rengaswamy, Basu, Partha, Kaur, Prabhdeep, Bhaskar, Rajesh, Singh, Gurinder Bir, Denzongpa, Phumzay, Grover, Rajesh K, Sebastian, Paul, Saikia, Tapan, Oswal, Kunal, Kanodia, Rishav, Dsouza, Amantia, Mehrotra, Ravi, Rath, Goura Kishor, Jaggi, Viniita, Kashyap, Sundram, Kataria, Ishu, Hariprasad, Roopa, Sasieni, Peter, Bhatla, Neerja, Rajaraman, Preetha, Trimble, Edward L, Swaminathan, Soumya, Purushotham, Arnie·2019·The Lancet Oncology

DOI 10.1016/s1470-2045(19)30531-5

Open this paper in CoChat — free account

Abstract

Efforts are being made to scale up human papillomavirus (HPV) vaccination for adolescent girls in India. Bivalent and quadrivalent HPV vaccines were licensed in the country in 2008, and a nonavalent vaccine was licensed in 2018. Demonstration projects initiated in Andhra Pradesh and Gujarat in 2009 introduced HPV vaccination in public health services in India. Following a few deaths in these projects, although subsequently deemed unrelated to vaccination, HPV vaccination in research projects was suspended. This suspension by default resulted in some participants in a trial evaluating two versus three doses receiving only one dose. Since 2016, the successful introduction of HPV vaccination in immunisation programmes in Punjab and Sikkim (with high coverage and safety), government-sponsored opportunistic vaccination in Delhi, prospects of a single dose providing protection, and future availability of an affordable Indian vaccine shows promise for future widespread implementation and evaluation of HPV vaccination in India.

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(19)30531-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Worldwide burden of cancer attributable to HPV by site, country and HPV type
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30716 · Cited by 2,330
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Cancer of the cervix uteri
Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12611 · Cited by 1,279
Self-citation
Cancer of the cervix uteri
Bermúdez, A., Bhatla, N., & Leung, E. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.06.004 · Cited by 668
Self-citation
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Garland, S. M., Kjær, S. K., Muñóz, N., Block, S. L., Brown, D. R., DiNubile, M. J., Lindsay, B. R., Kuter, B. J., Pérez, G., Dominiak-Felden, G., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw354 · Cited by 553
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.-B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30836-2 · Cited by 486
Cervical cancer screening: who is not screened and why?
Harlan, L. C., Bernstein, A. B., & Kessler, L. G. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.7.885 · Cited by 485
The projected timeframe until cervical cancer elimination in Australia: a modelling study
Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Brotherton, J. M. L., Saville, M., Frazer, I. H., & Canfell, K. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30183-x · Cited by 448
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations.
Turner, N. (2009) · PubMed · Cited by 298
Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries
Denny, L., de Sanjose, S., Mutebi, M., Anderson, B. O., Kim, J., Jeronimo, J., Herrero, R., Yeates, K., Ginsburg, O., & Sankaranarayanan, R. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31795-0 · Cited by 246
Self-citation

Show all 42 references

Research works printed but not linked: 2

2010, Concerns around the human papillomavirus (HPV) vaccine, Indian J Med Ethics, 7, 38
Choudhury, 2010, Human papillomavirus vaccines and current controversy, Indian Paediatr, 47, 724

Sorted by citations

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00453-8 · Cited by 272
Self-citation
A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries
Moola, S., Gudi, N., Nambiar, D., Dumka, N., Ahmed, T., Sonawane, I. R., & Kotwal, A. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05027 · Cited by 107
Epidemiology of HPV Related Malignancies
Scott‐Wittenborn, N., & Fakhry, C. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.04.001 · Cited by 95
Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease
Yang, M., Du, J., Lu, H. J., Xiang, F., Mei, H., & Xiao, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055470 · Cited by 86
Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management
Mehrotra, R., & Yadav, K. (2021) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-021-00602-z · Cited by 84
Self-citation
Cervical cancer prevention efforts in India
Bhatla, N., Meena, J., Kumari, S., Banerjee, D., Singh, P., & Natarajan, J. (2021) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-021-00526-8 · Cited by 63
Self-citation
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage
Giannone, G., Giuliano, A. R., Bandini, M., Marandino, L., Raggi, D., Earle, W., Ayres, B. E., Pettaway, C. A., McNeish, I. A., Spiess, P. E., et al. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102467 · Cited by 62
Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019
Ahmed, D., VanderEnde, K., Harvey, P., Bhatnagar, P., Kaur, N., Roy, S., Singh, N., Denzongpa, P., Haldar, P., & Loharikar, A. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.07.024 · Cited by 58
Self-citation
Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity
Kamaraju, S., Drope, J. M., Sankaranarayanan, R., & Shastri, S. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280625 · Cited by 60
Self-citation
The impact of health education interventions on HPV vaccination uptake, awareness, and acceptance among people under 30 years old in India: a literature review with systematic search
Krokidi, E., Rao, A. P., Ambrosino, E., & Thomas, P. P. M. (2023) · Frontiers in Reproductive Health · doi:10.3389/frph.2023.1151179 · Cited by 60
Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses
Lin, Z., Li, X., Shi, H., Cao, R., Zhu, L., Dang, C., Sheng, Y., Fan, W., Yang, Z., & Wu, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1351287 · Cited by 54
Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme
Ramamoorthy, T., Sathishkumar, K., Das, P., Sudarshan, K. L., & Mathur, P. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1444 · Cited by 53
Cervical cancer in Nepal: Current screening strategies and challenges
Narasimhamurthy, M., & Kafle, S. U. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980899 · Cited by 56
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
Sharma, H., Parekh, S. S., Pujari, P., Shewale, S. D., Desai, S., Bhatla, N., Joshi, S., Pimple, S. A., Kawade, A. S., Balasubramani, L., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00480-1 · Cited by 52
Self-citation
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
Man, I., Georges, D., de Carvalho, T. M., Ray Saraswati, L., Bhandari, P., Kataria, I., Siddiqui, M., Muwonge, R., Lucas, E., Berkhof, J., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00543-5 · Cited by 44
Self-citation
Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019
Wu, S., Jiao, J., Yue, X., & Wang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1358433 · Cited by 42
IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity”
Garland, S. M., Stanley, M., Giuliano, A. R., Moscicki, A., Kaufmann, A. M., Bhatla, N., Woo, Y. L., Palefsky, J. M., Chan, K., & Brotherton, J. M. L. (2020) · Papillomavirus Research · doi:10.1016/j.pvr.2020.100195 · Cited by 35
Self-citation
Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine—Navi Mumbai, India, 2018
Date, K., Shimpi, R., Luby, S. P., Ramaswami, N., Haldar, P., Katkar, A., Wannemuehler, K. A., Mogasale, V., Pallas, S. W., Song, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa597 · Cited by 28
Human papilloma virus vaccines: A comprehensive narrative review
Aggarwal, S. S., Agarwal, P., & Singh, A. (2023) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2023.100780 · Cited by 32
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
Zhou, X., Sun, L., Yao, X., Li, G., Wang, Y., & Lin, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01434 · Cited by 27
Impact of HPV vaccination on HPV-related oral infections
Gheit, T., Muwonge, R., Lucas, E., Galati, L., Anantharaman, D., McKay‐Chopin, S., Malvi, S. G., Jayant, K., Joshi, S., Esmy, P. O., et al. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.106244 · Cited by 27
Self-citation
A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide
Aggarwal, S. S., Agarwal, P., & Gupta, N. (2024) · Cancer Medicine · doi:10.1002/cam4.6862 · Cited by 26
A qualitative analysis of vaccine decision makers’ conceptualization and fostering of ‘community engagement’ in India
Dutta, T., Meyerson, B. E., Agley, J. D., Barnes, P. A., Sherwood‐Laughlin, C., & Nicholson‐Crotty, J. (2020) · International Journal for Equity in Health · doi:10.1186/s12939-020-01290-5 · Cited by 25
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study
Portnoy, A., Abbas, K., Sweet, S., Kim, J. J., & Jit, M. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006940 · Cited by 23
HPVsim: An agent-based model of HPV transmission and cervical disease
Stuart, R. M., Cohen, J. A., Kerr, C. C., Mathur, P., Abeysuriya, R., Zimmermann, M. R., Rao, D. W., Boudreau, M. C., Lee, S., Yang, L., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012181 · Cited by 31
Prevalence of high‐risk HPV and its genotypes—Implications in the choice of prophylactic HPV vaccine
Suresh, A., Suresh, P., Biswas, R., Rajanbabu, A., Sreedhar, S., & Biswas, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27015 · Cited by 24
A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer
Theivendren, P., Hegde, Y. M., Srinivas, G., Palanivel, M., Shanmugam, N., Kunjiappan, S., Sivakumar, V., Gopal, M., & Dharmalingam, S. R. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220513160706 · Cited by 25
Building resilient cervical cancer prevention through gender-neutral HPV vaccination
Man, I., Georges, D., Sankaranarayanan, R., Basu, P. S., & Baussano, I. (2023) · eLife · doi:10.7554/elife.85735 · Cited by 24
Self-citation
Cancer prevention and control in India can get a boost through primary health care-based approach: A review
Lohiya, A., Daniel, R. A., Smith, R. D., Nagar, M., Shankar, A., & Lahariya, C. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2378_21 · Cited by 21
Factors explaining men’s intentions to support their partner’s participation in cervical cancer screening
Dsouza, J. P., Van den Broucke, S., Pattanshetty, S., & Dhoore, W. (2022) · BMC Women's Health · doi:10.1186/s12905-022-02019-y · Cited by 20
Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
Kataria, I., Siddiqui, M., Treiman, K., Foley, S., Anand, M., Biswas, S., Shastri, D., Bhatla, N., Radhakrishnan, D., Mamidi, P., et al. (2022) · Vaccine: X · doi:10.1016/j.jvacx.2022.100228 · Cited by 20
Self-citation
Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low‐ and lower‐middle‐income countries
Kumar, S., Khanduri, A., Sidibe, A., Morgan, C., Torode, J., Basu, P. S., Bhatla, N., Schocken, C., & Bloem, P. N. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13482 · Cited by 20
Self-citation
Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer
Vani, N. V., Madhanagopal, R., Swaminathan, R., & Ganesan, T. S. (2023) · Cancer Medicine · doi:10.1002/cam4.5686 · Cited by 18
Media news on vaccines and vaccination: The content profile, sentiment and trend of the online mass media during 2015–2020 in India
Das, M. K., Singh, D., & Sharma, S. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2020.100691 · Cited by 19
Cervical Cancer in Low- and Middle-Income Countries: A Multidimensional Approach to Closing the Gaps
Mullapally, S. K., Digumarti, L., & Digumarti, R. (2022) · JCO Oncology Practice · doi:10.1200/op.22.00156 · Cited by 20
Designing a pro-equity HPV vaccine delivery program for girls who have dropped out of school: community perspectives from Uttar Pradesh, India
Holroyd, T. A., Yan, S. D., Srivastava, V., Srivastava, A., Wahl, B., Morgan, C., Kumar, S., Yadav, A. K., & Jennings, M. C. (2022) · Health Promotion Practice · doi:10.1177/15248399211046611 · Cited by 18
Cervical cancer elimination in Indian context: Moving from barriers to facilitators
Vikraman, S. M., Khanna, D., & Dandpat, A. (2022) · Cancer · doi:10.1002/cncr.34486 · Cited by 18
Epidemiology of Gynaecological Cancers
Kataki, A. C., Tiwari, P., Thilagavthi, R., & Krishnatreya, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-5860-1_1 · Cited by 17
An exploratory study of undergraduate healthcare student perspectives regarding human papillomavirus and vaccine intent in India
Shetty, S., Shetty, V., Badiger, S. B., & Shetty, A. K. (2021) · Women s Health · doi:10.1177/17455065211055304 · Cited by 21
Cervical cancer burden in India: A descriptive epidemiological study and policy insights
Singh, K., Grover, A., & Dhanasekaran, K. (2025) · Global Epidemiology · doi:10.1016/j.gloepi.2025.100233 · Cited by 23
HPV vaccination and factors influencing vaccine uptake among people of Indian ancestry living in the United States
Ratnasamy, P. P., & Chagpar, A. B. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822001315 · Cited by 16
Time for enhancing government-led primary prevention of cervical cancer
Min, K., Suh, D. H., Baba, T., Chen, X., Kim, J., Kobayashi, Y., Kwon, J. S., Lim, M. C., Lee, J., Nagase, S., et al. (2020) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2021.32.e12 · Cited by 14
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study
Muwonge, R., Basu, P. S., Gheit, T., Anantharaman, D., Verma, Y., Bhatla, N., Joshi, S., Esmy, P. O., Poli, U. R., Shah, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244242 · Cited by 14
Self-citation
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
Jerajani, K., Wan, Y., Hickey, J. M., Kumru, O. S., Sharma, N. N., Pullagurla, S. R., Ogun, O., Mapari, S., Whitaker, N., Brendle, S. A., et al. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.07.019 · Cited by 13
Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India
Bhatla, N., Meena, J., Gupta, K., Pal, B., Divakar, H., Bhalerao, S., Peedicayil, A., Srivastava, S., Basu, P. S., Purandare, C. N., et al. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14345 · Cited by 14
Self-citation
Challenges and opportunities to making Indian women cervical cancer free
Gupta, S., Kumar, P. N., & Das, B. C. (2023) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1052_23 · Cited by 13
Cervical cancer kills 300,000 people a year — here’s how to speed up its elimination
Denny, L., Kataria, I., Huang, L. L., & Schmeler, K. M. (2024) · Nature · doi:10.1038/d41586-024-00241-2 · Cited by 12
Self-citation
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
de Carvalho, T. M., Man, I., Georges, D., Saraswati, L. R., Bhandari, P., Kataria, I., Siddiqui, M., Muwonge, R., Lucas, E., Sankaranarayanan, R., et al. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012580 · Cited by 12
Self-citation
Evidence on factors influencing HPV vaccine implementation in South Asia: A scoping review
Rajkhowa, P., Patil, D. S., Dsouza, S. M., Narayanan, P., & Brand, H. (2023) · Global Public Health · doi:10.1080/17441692.2023.2288269 · Cited by 13
Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review
Kaur, K. N., Niazi, F., Nandi, D., & Taneja, N. (2024) · Cancer Control · doi:10.1177/10732748241285184 · Cited by 13
Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study
Coursey, K., Muralidhar, K., Srinivas, V., Jaykrishna, P., Begum, F., Ningaiah, N., Lee, S.-J., & Madhivanan, P. (2024) · BMC Public Health · doi:10.1186/s12889-024-19485-8 · Cited by 10
“While HPV vaccines have been approved for Indian school-aged girls since 2008, the government of India temporarily halted vaccine studies in 2010 after the deaths of seven young girls who received HPV vaccination through implementation projects in the states of Gujarat and Andhra Pradesh [4].”
Background
A Study to Assess the Impact of Education on the Knowledge and Attitude Toward Cervical Cancer and HPV (Human Papillomavirus) Vaccination Among Female Healthcare Students
Verma, I., Bajpai, R., Arjaria, V., Garg, L., Mungad, A., Singh, D., Gavli, J., & Khare, A. (2024) · Cureus · doi:10.7759/cureus.59856 · Cited by 15
Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions
Gupta, K., Mandal, R., & Chatterjee, P. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16030 · Cited by 10
Assessment of understanding about human papilloma virus vaccination among undergraduate medical students in a developing country: Perspective from India
Sharma, C., Singh, P., Arora, I. K., Bhardwaj, A., Saini, A., Gothwal, M., & Jhirwal, M. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_893_20 · Cited by 13
Comparison of two self‐sampling methods for human papillomavirus (HPV) DNA testing among women with high prevalence rates
Kuriakose, S., Sabeena, S., Binesh, D., Ravishankar, N., Ramachandran, A., & Ameen, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26043 · Cited by 9
Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival
Mahapatra, E., Das, S., Biswas, S., Ghosh, A., Sengupta, D., Roy, M., & Mukherjee, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98489 · Cited by 10
Demand and willingness to pay for human papilloma virus vaccine for their daughters among mothers in Haryana, India: A contingent valuation study
Ray, S., Mulchandani, R., & Patel, P. (2024) · Journal of Health Services Research & Policy · doi:10.1177/13558196231215969 · Cited by 8
Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians
Dwivedi, P., Lahariya, A. U., Pandey, S., Sreedevi, A., Lohiya, A., & Lahariya, C. (2024) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_16_23 · Cited by 9
Experience of Human Papillomavirus Vaccination Project in a Community Set Up-An Indian Study
Mandal, R., Banerjee, D., Gupta, K., Chatterjee, P., Vernekar, M., & Ray, C. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.699 · Cited by 8
Factors influencing HPV vaccine implementation in South Asia: a scoping review protocol
Rajkhowa, P., Pundir, P., Dsouza, S. M., Patil, D. S., Narayanan, P., & Brand, H. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02415-x · Cited by 7
Leveraging single-dose human papillomavirus vaccination dose-efficiency to attain cervical cancer elimination in resource-constrained settings
Man, I., Georges, D., Basu, P. S., & Baussano, I. (2024) · JNCI Monographs · doi:10.1093/jncimonographs/lgae035 · Cited by 7
Self-citation
The Trend and Prediction of Cervical Cancer Incidence in Delhi, India: An Age-Period-Cohort Analysis
Malhotra, R. K., Manoharan, N., & Deo, S. S. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.8.2787 · Cited by 7
A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
Haruyama, R., Okawa, S., Akaba, H., Obara, H., & Fujita, N. (2021) · Vaccines · doi:10.3390/vaccines9111355 · Cited by 9
Geospatial mapping of public sentiment and infodemic on human papillomavirus vaccination in India: An indication to formulation of strategies for effective implementation
Rajkhowa, P., Cauvery, K., Rakshitha, K., Dsouza, V. S., Pattanshetty, S. M., Narayanan, P., Saravu, K., & Brand, H. (2024) · Global Public Health · doi:10.1080/17441692.2024.2348646 · Cited by 7
CMTM6 as a candidate risk gene for cervical cancer: Comprehensive bioinformatics study
Huang, X., Liu, W., Liu, C., Hu, J., Wang, B., Ren, A., Huang, X., Yuan, Y., Liu, J., & Li, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.983410 · Cited by 6
Retracted
Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India
Man, I., Georges, D., Bonjour, M., & Baussano, I. (2023) · eLife · doi:10.7554/elife.81752 · Cited by 6
Google Trends for the Human Papillomavirus Vaccine in India From 2010 to 2024: Infodemiological Study
Mehra, R., Ray, A., Kumari, A., Kaur, A., Hora, R., Quadri, S. F., Koshal, S. S., Ray, B., Singh, S. K., Sultana, A., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/69729 · Cited by 8
Primary Prevention in Cervical Cancer—Current Status and Way Forward
Patel, M. A. (2024) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-024-02048-7 · Cited by 5
Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study
Khiari, H., Makni, K., Meddeb, K., Jaïdane, O., & Hsaïri, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085462 · Cited by 6
A questionnaire study on disparity of cervical cancer prevention programs in Asia‐Oceania
Tse, K. Y., Ushijima, K., Tan, A. L., Inthasorn, P., Pariyar, J., Chang, C., Domingo, E. J., Konar, H., Kumarasamy, S., Tjokroprawiro, B. A., et al. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15566 · Cited by 6
Awareness of cervical cancer among women aged 18-25 years in rural areas
Patil, K. M., & Sawant, S. S. (2023) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20232365 · Cited by 5
Introduction of HPV vaccine in universal immunization programme of India: A step in the right direction for the elimination of cervical cancer
Bashar, M., & Khan, I. A. (2024) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_26_23 · Cited by 5
Knowledge, Attitudes, Beliefs and Willingness to Recommend Human Papillomavirus (HPV) Vaccination among Medical Students in Mysore, India
Dept. of Community Medicine, M. M. C. A. R. I., & Khan, M. (2021) · International Journal of Preventive, Curative & Community Medicine · doi:10.24321/2454.325x.202015 · Cited by 4
Human papillomavirus vaccine: Success and challenges
Gupta, C., Dolma, K. G., Sherpa, M. L., Bag, A., & Byahut, A. (2025) · Journal of Biosciences · doi:10.1007/s12038-025-00493-8 · Cited by 5
Perceptions and sentiments associated with HPV vaccine uptake among Indian Reddit users: a qualitative social media analysis
Singh, G. P., Dash, N. R., Shaju, A., & Chakkalakkunnan, S. S. (2025) · BMC Public Health · doi:10.1186/s12889-025-25418-w · Cited by 6
Self-citation
A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer
Lin, Y., Zhang, R., Pan, H., & Li, Y. (2023) · Medical Science Monitor · doi:10.12659/msm.938660 · Cited by 5
FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV
Amaral, E. M., Cain, J. M., Hearing, F., & Lumsden, M. A. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14894 · Cited by 4
Knowledge, attitude and practice towards cervical cancer screening and human papilloma virus vaccine at a tertiary care facility in North India
Misra, D., Mahajan, C., & Bansal, B. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20202748 · Cited by 4
Postvaccination prevalence of vaccine‐Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta‐analysis
Sabeena, S., & Ravishankar, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26968 · Cited by 4
Validation of the 5C questionnaire to assess the hesitancy towards adult vaccination among the Hindi speaking population of Northern India
Gandhi, A. P., Kiran, T., Thakur, J., Sharma, D., Junaid, K. P., Gupta, R., Prajapati, A., & Amaljith, A. B. (2024) · Discover Social Science and Health · doi:10.1007/s44155-024-00061-9 · Cited by 5
Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries
Hande, V., Ranjan, N., Chopra, S., Sinha, S., Mittal, P., Gupta, A., Maheshwari, A., & Gupta, S. (2024) · JCO Global Oncology · doi:10.1200/go.23.00478 · Cited by 4
HPVsim: An agent-based model of HPV transmission and cervical cancerPreprint
Stuart, R. M., Cohen, J. A., Kerr, C. C., Mathur, P., Abeysuriya, R., Zimmermann, M. R., Rao, D. W., Boudreau, M. C., Lee, S., Yang, L., et al. (2023) · medRxiv · doi:10.1101/2023.02.01.23285356 · Cited by 4
Parental perspectives: a mixed method study on perceived risk, self-efficacy, vaccine response efficacy, and willingness for adolescent HPV vaccination in Puducherry, South India
Narayanan, S., Murugan, A., Ramakrishnan, J., Udayakumar, K. R. P., Raj, R., & Thulasingam, M. (2025) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2024-0096 · Cited by 3
From hesitancy to hope: charting India’s path to widespread HPV immunisation
Khastgir, G., Saha, P. K., & Bagga, R. (2025) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2025.2575222 · Cited by 3
“Why to Vaccinate Her? She’s Just a Girl”: Exploring Challenges and Opportunities in Cervical Cancer Care in India
Moin, S., & Singh, P. (2026) · ACM Transactions on Computing for Healthcare · doi:10.1145/3803412 · Cited by 3
Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State
Krishna, E., Patil, S., Nirala, S. K., Naik, B. N., Kumar, V., Singh, C. M., & Kumar, V. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1277_24 · Cited by 4
Therapeutic HPV Vaccination: A Strategy for Cervical Cancer Elimination in India
Ali, S. S., Nirupama, A. Y., Chaudhuri, S., & Murthy, G. V. S. (2024) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-024-00800-5 · Cited by 2
Introduction to Cancer World
Mohanti, B. K., Mathur, P., Jayarajah, U., Biswal, B. M., & Prinja, S. (2025) · Springer eBooks · doi:10.1007/978-981-97-8389-2_1 · Cited by 3
Good News! Indigenous HPV Vaccine on Shelf by this Year End what India Must do to Hasten Cervical Cancer Elimination by 2030?
Kishanrao, S. (2022) · Journal of Quality in Health Care & Economics · doi:10.23880/jqhe-16000296 · Cited by 3
Universal Cervical Cancer Immunization: India Ready for a Quantum Leap
Ahuja, M., Sharma, P., & Sarkar, A. (2022) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_224_22 · Cited by 3
Overcoming disparities to improve cancer care: The story of cervical cancer
Duska, L. (2022) · Cancer · doi:10.1002/cncr.34488 · Cited by 3
Assessing knowledge and awareness levels regarding cervical cancer and HPV vaccination in the Jammu regions
Jasrotia, R., Kashyap, I., Suri, J., Chopra, C., Wani, A. K., Tizro, N., Goyal, A., & Singh, R. (2024) · Iranian Journal of Microbiology · doi:10.18502/ijm.v16i4.16311 · Cited by 2
Effect of educational intervention on knowledge of HPV and HPV vaccine and vaccine acceptability among teachers: A pilot investigation
Ghosh, S., Bhatnagar, P., & Chhabra, R. (2025) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_1032_23 · Cited by 2
Temporal trends in cervical cancer incidence and mortality in economically emerging countries, 1992–2021: an age-period-cohort analysis
Dun, C., Su, Y., Basu, P. S., Zhao, X., Hu, S., Muwonge, R., Qiao, Y., & Zhao, F. (2026) · BMJ Global Health · doi:10.1136/bmjgh-2024-018569 · Cited by 2
Self-citation
Single dose nonavalent HPV vaccine – need of the hour
Bandyopadhyay, S., & Pal, M. (2020) · Nepal Journal of Epidemiology · doi:10.3126/nje.v10i2.28962 · Cited by 2
Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections Among Asian Young Adult Women With Perinatally Acquired HIV Compared With HIV-Negative Peers
Sohn, A. H., Chalermchockcharoenkit, A., Teeraananchai, S., Hansudewechakul, R., Gatechompol, S., Chokephaibulkit, K., Dang, H. L. D., Tran, D. N. H., Achalapong, J., Teeratakulpisarn, N., et al. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001294 · Cited by 2
Health and economic effects of introducing single-dose human papillomavirus vaccination in IndiaPreprint
de Carvalho, T., Man, I., Georges, D., Saraswati, L., Bhandari, P., Kataria, I., Siddiqui, M., Muwonge, R., Lucas, E., Sankaranarayanan, R., et al. (2023) · medRxiv · doi:10.1101/2023.04.14.23288563 · Cited by 2
Self-citation
No Family Should Suffer From Cervical Cancer Twice–The Palliative Care Role in HPV Prevention
Iyengar, S. S., Kantor, K., Cyriac, S. L., Remadevi, K., Usha, V., Robinson, S., Rani, A., Rajagopal, M. R., & Broderick, A. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.06.022 · Cited by 1
"High incidence of abnormal pap smears and low awareness of cervical cancer among women in Rewa, Madhya Pradesh, India: Implications for screening and education"
Nigudgi, A., Tiwari, P., Chandel, H. S., & Singh, P. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102767 · Cited by 1
China’s actions for post-political commitment to global strategy to accelerate cervical cancer elimination
Huang, H.-Y., Du, C., & Liu, G. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00708-5 · Cited by 1

Authors: Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R. K., Sebastian, P., Saikia, T., Oswal, K., Kanodia, R., Dsouza, A., Mehrotra, R., Rath, G. K., Jaggi, V., Kashyap, S., Kataria, I., Hariprasad, R., Sasieni, P., Bhatla, N., Rajaraman, P., Trimble, E. L., Swaminathan, S., & Purushotham, A.
Affiliations: RTI International (US)
World Health Organization (CH)
Indian Council of Medical Research (IN)
Government of Sikkim (IN)
Delhi State Cancer Institute (IN)
Tata Trusts (IN)
Prince Aly Khan Hospital (IN)
DR. B.R.A. Institute Rotary Cancer Hospital (IN)
King's College London (GB)
All India Institute of Medical Sciences (IN)
United States Department of Health and Human Services (US)
National Cancer Institute (US)
Corresponding author: Basu, Partha
ORCID: Sankaranarayanan, Rengaswamy
Basu, Partha
Kaur, Prabhdeep
Singh, Gurinder Bir
Oswal, Kunal
Mehrotra, Ravi
Kataria, Ishu
Hariprasad, Roopa
Sasieni, Peter
Bhatla, Neerja
Rajaraman, Preetha
Trimble, Edward L
Swaminathan, Soumya
Purushotham, Arnie
Venue: The Lancet Oncology
Publisher: Elsevier BV
Published: 2019-11
Volume: 20
Issue: 11
Pages: e637-e644
ISSN: 1470-2045 (ISSN-L)
DOI: 10.1016/s1470-2045(19)30531-5
OpenAlex: W2982439965
Cited by: 136
References: 42
Citations by year: 2026: 13 · 2025: 16 · 2024: 27 · 2023: 18 · 2022: 24 · 2021: 21 · 2020: 17
FWCI: 2.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Oncology (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: Indian Council of Medical Research
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords: HPV vaccination, cervical cancer prevention, adolescent girls, immunization programs, bivalent HPV vaccine, quadrivalent HPV vaccine, nonavalent HPV vaccine, India
MeSH terms: Uterine Cervical Neoplasms, Female, Health Policy, Humans, India, Policy Making, Prognosis, Risk Factors, Vaccination, Immunization Programs, Risk Assessment, Papillomavirus Infections, Papillomavirus Vaccines, Disease Eradication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks